KLA Corporation -- 8.7/10 -- $1,516.84
KLA Corporation is the undisputed monopoly in semiconductor process control -- the inspection and metrology tools that ensure chip manufacturing yields. With ~55% market share, KLA is 6.5x larger than the #2 player, and its share of wafer fab equipment (WFE) spending has grown ~250bps over the past five years. Process control sits alongside lithography (ASML) and deposition/etch (AMAT/TEL) as one of three near-monopolies in semiconductor equipment, and KLA dominates its niche more thoroughly than any peer.
CY2025 was a record year across every key metric. Revenue reached $12.7B (+17% YoY), outpacing estimated WFE growth of mid-to-high single digits. Non-GAAP EPS grew 29% YoY. Free cash flow hit a record $4.4B (34% margin), up 30% YoY. The company operates an asset-light model with CapEx at just ~3% of revenue, translating nearly all operating income into free cash flow.
Every major trend in semiconductor manufacturing increases KLA demand. AI-driven complexity means larger die, more complex designs (gate-all-around), and higher-value wafers that demand more inspection. EUV lithography requires additional inspection layers -- in DRAM, EUV introduction added ~100bps of process control intensity. HBM architecture adds another ~100bps of intensity because there is less redundancy, bigger die with TSVs, more metallization layers, and tighter reliability specs. Memory now represents 40% of semi process control systems revenue, up from 18% two years ago -- a structural shift, not cyclical.
Advanced packaging is an entirely new served market. KLA generated $950M in advanced packaging revenue in CY2025, up 70%+ YoY. Process control share of advanced packaging WFE went from ~1% in 2021 to ~6% in 2025, approaching ~50% share of process control in packaging. Management expects mid-to-high teens growth in CY2026.
The services flywheel compounds relentlessly. Services revenue reached $786M in CQ4 2025, up 18% YoY -- the 16th consecutive year of annual service revenue growth with a 12%+ CAGR. Higher tool utilization (AI inference fabs run 24/7), a growing installed base, longer tool lifetimes, and higher ASP tools all compound the recurring revenue stream.
| Price | $1,516.84 | CY2025 Revenue | $12.7B (+17% YoY, record) |
| Market Cap | $199B | CY2025 Non-GAAP EPS | ~$35.45 (+29% YoY) |
| Process Control Share | ~55% (6.5x #2) | TTM Free Cash Flow | $4.4B (34% margin, record) |
| CEO | Rick Wallace (since 2006, 20 years) | Non-GAAP Op Margin | 43%+ (industry-leading) |
| P/E (FY2026E) | ~43x Non-GAAP EPS | Non-GAAP Gross Margin | 62.6% (best-in-class semi equip) |
| Dimension | Score | Weight | Weighted |
|---|---|---|---|
| Financial Trends | 9.2 | 25% | 2.30 |
| Thematic Exposure | 9.2 | 25% | 2.30 |
| Management Quality | 9.0 | 20% | 1.80 |
| Investor Sentiment (Inverted) | 8.0 | 15% | 1.20 |
| Concerns / Risks | 7.3 | 15% | 1.10 |
| Composite | 100% | 8.70 |
KLAC receives a composite score of 8.7/10, reflecting the widest moat in semiconductor equipment with structurally expanding demand drivers and best-in-class financial execution.
1. Process control monopoly with expanding relevance. KLA holds ~55% of the semiconductor process control market -- 6.5x the size of the #2 player. Over the past five years, process control share of WFE has grown ~250bps, and KLA has gained share within process control as well. The optical physics, precision engineering, and decades of customer process data create barriers that no competitor -- domestic Chinese or otherwise -- can replicate. Every node shrink, every new architecture (gate-all-around, HBM, advanced packaging), and every proliferation of custom silicon increases the need for inspection.
2. HBM and advanced packaging are structural growth vectors. The DRAM process control intensity revolution is the most significant shift in KLA demand in years. HBM added ~200bps of incremental inspection intensity, and memory now represents 40% of semi process control systems revenue vs. 18% two years ago. Advanced packaging revenue of $950M in CY2025 (up 70%+ YoY) represents an entirely new served market growing faster than core WFE.
3. Services flywheel and financial discipline. Services have grown every year for 16 consecutive years at a 12%+ CAGR, now running at $786M per quarter. The combination of 62%+ gross margins, 43%+ operating margins, 34% FCF margins, and consistent capital return ($3.0B LTM) makes KLA one of the highest-quality compounders in technology.
Bull case: Process control intensity continues rising structurally. HBM, advanced packaging, and e-beam create multiple growth vectors beyond core WFE. CY2026 revenue guided mid-single-digit growth but supply constraints and H2 acceleration could deliver upside. Services accelerate to high-teens growth. Gross margins recover to 63%+ as DRAM component cost headwinds normalize by CY2027.
Bear case: China export restrictions tighten further, compressing revenue by more than the $300-350M already absorbed. WFE cyclicality returns with a sharp downturn. Gross margins remain below 63% longer than expected. Valuation at ~43x forward leaves no room for execution misses. Clean room capacity constraints delay revenue realization.
Key catalysts and monitoring points:
- CY2026 WFE trajectory and H2 acceleration: Management guides core WFE to low $120B range plus ~$12B advanced packaging (~$135B total). KLA expects mid-single-digit revenue growth with an H2 acceleration narrative. Watch for CQ1 2026 guidance commentary on order trends and capacity additions.
- China revenue normalization: China declining from ~30% to mid-20s as a percentage of revenue is guided. Further export restrictions remain a tail risk -- each round has been broader than the last. Track quarterly China revenue mix and management commentary on policy developments.
- Memory mix and HBM intensity: Memory rose to 40% of semi process control systems revenue in CQ4 2025, with DRAM 85% of memory. This structural shift is the key driver of above-WFE growth. Watch for memory share sustaining at 35-40%+ as confirmation of permanence.
- Gross margin recovery path: Guided 62% +/- 50bps for CY2026 with DRAM component cost inflation and tariff headwinds. Management expects return to 63%+ by CY2027. Any further compression would pressure the premium multiple.
- Advanced packaging growth: $950M in CY2025, guided mid-to-high teens growth in CY2026. This is the fastest-growing segment and the most direct AI-linked revenue stream. Track quarterly commentary on sampling rates and customer pull-in.
- 2022 Investor Day $14B revenue target: Management confirmed KLA does not need $125B WFE to achieve $14B in CY2026 given share gains. Hitting this target would validate the structural outperformance thesis.
For the full analysis, see the Business Model, Financials, and Valuation pages.
Concerns, Catalysts & Risks -- full analysis
Buy at current levels -- KLA is the highest-quality franchise in semiconductor equipment with the widest moat, structurally expanding demand, and a 10% pullback from the all-time high providing a reasonable entry. At ~43x FY2026E non-GAAP EPS (~$35.60 consensus), KLAC commands the highest premium in semi equipment -- but the premium is earned by monopoly market position, industry-leading margins, structural share gains, and superior FCF conversion.
The key insight is that multiple growth vectors are underappreciated simultaneously: (1) the DRAM process control intensity shift from HBM is permanent, not cyclical -- memory at 40% of systems revenue is a new baseline; (2) advanced packaging at $950M and growing 70%+ is an entirely new SAM not fully in long-term models; (3) e-beam revenue doubling creates a new product line with further share gains ahead; (4) custom silicon proliferation from hyperscalers generates incremental design starts beyond traditional foundry customers; (5) services at 18% growth are running above the 12-14% long-term target with no signs of deceleration.
Key position-sizing considerations: (1) the ~43x forward multiple is the highest in semi equipment, meaning any WFE downturn or earnings miss could trigger significant multiple contraction; (2) China at mid-20s of revenue remains a policy risk with each restriction round historically broader than the last; (3) gross margins at 62% are below the long-term 63%+ model with recovery not expected until CY2027; (4) clean room capacity constraints are real and could cap near-term upside even as demand remains strong. The monopoly quality of the franchise and the breadth of structural growth drivers warrant a Buy, but position sizing should reflect the premium valuation and China policy exposure.